Cann American Corp. logo

Cann American Corp. (CNNA)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
0. 01
+0
+10%
$
4.43M Market Cap
- P/E Ratio
- Div Yield
44,000 Volume
0 Eps
$ 0.01
Previous Close
Add Transaction
Day Range
0.01 0.01
Year Range
0 0.01
Want to track CNNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CNNA closed yesterday higher at $0.01, an increase of 10% from Friday's close, completing a monthly increase of 65% or $0. Over the past 12 months, CNNA stock gained 560%.
CNNA is not paying dividends to its shareholders.
The last earnings report, released on Aug 31, 2014, missed the consensus estimates by -0.0001%. On average, the company has fell short of earnings expectations by -0.0001%, based on the last three reports.
Cann American Corp. has completed 3 stock splits, with the recent split occurring on Nov 13, 2020.
The company's stock is traded on one exchange.

CNNA Chart

Cann American Corp. (CNNA) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Cann American Corp. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is CNNA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.43M.

Has Cann American Corp. ever had a stock split?

Cann American Corp. had 3 splits and the recent split was on Nov 13, 2020.

Cann American Corp. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Jason R. Tucker CEO
OTC PINK Exchange
13764N207 CUSIP
US Country
1 Employees
- Last Dividend
13 Nov 2020 Last Split
- IPO Date

Overview

Cann American Corp., originally founded as Canamed4Pets, Inc., transitioned its corporate identity in December 2019 to reflect a broader mission within the healthcare sector. Established in 2004 and headquartered in Orlando, Florida, this development stage company has dedicated itself to revolutionizing healthcare solutions. By focusing on innovative therapies, Cann American Corp. strives to make healthcare not only more affordable but also more accessible to a wide range of patients. The company leverages cutting-edge technology with the aim of reducing healthcare costs while simultaneously improving the quality and availability of healthcare services, ensuring that high-quality care is within reach for all patients.

Products and Services

Cann American Corp. is actively engaged in the development and implementation of a variety of products and services designed to fulfill its mission of advancing healthcare solutions:

  • Innovative Therapies: The core of Cann American Corp.'s offerings revolves around the development of new and innovative therapies intended to address unmet healthcare needs. These therapies are developed with the aim of making significant contributions to the field of medicine, focusing on both the efficacy and accessibility of treatment options.
  • Cutting-Edge Technology: Leveraging the latest advancements in technology, Cann American Corp. is devoted to enhancing the efficiency of healthcare delivery. This includes the use of digital health platforms, telemedicine services, and other technological solutions that can help in reducing the overall costs of care while improving patient outcomes and access to medical services.
  • Affordability and Accessibility Initiatives: A key part of the company’s strategy involves initiatives aimed at making healthcare more affordable and accessible. By working on lowering the costs of treatments and improving the distribution channels, Cann American Corp. aims to ensure that more patients can access the high-quality care they need without being burdened by prohibitive costs.

Contact Information

Address: 121 South Orange Avenue
Phone: 770-866-6250